Results 141 to 150 of about 90,240,046 (296)
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Pulmonary Vein Thrombus After Mitral Valve Transcatheter Edge-to-Edge Repair
A 76-year-old female with a complicated medical history presented for Watchman (Boston Scientific) placement 2 months after mitral valve transcatheter edge-to-edge repair (TEER).
Aakash Rana +3 more
doaj +1 more source
AIM To identify anatomical computed tomography (CT) predictors of procedural and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair (T-TEER).
J. Bartkowiak +9 more
semanticscholar +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy.
BACKGROUND Untreated severe tricuspid regurgitation (TR) carries a poor prognosis. OBJECTIVES The authors report the 1-year outcomes of transcatheter edge-to-edge repair (TEER) with the TriClip system (Abbott Structural Heart) in patients with complex ...
David H. Adams +28 more
semanticscholar +1 more source
Transcatheter mitral valve repair: from edge-to-edge to annuloplasty
With more than 35,000 procedures worldwide, percutaneous edge-to-edge repair using MitraClip® is by far the most widely used percutaneous mitral valve intervention for the treatment of mitral regurgitation.
Mehdi Eskandari, Mark J. Monaghan
core +1 more source
PANoptosis in the pathogenesis of myelodysplastic syndromes
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla +4 more
wiley +1 more source
Hypoxia Following Mitral Transcatheter Edge-to-Edge Repair
Background Mitral regurgitation (MR) is a common disorder associated with increased risk of morbidity and mortality. Transcatheter edge-to-edge repair (TEER) is a minimally invasive option that is increasingly used in the management of this condition ...
Fajer J. Almoosa +4 more
semanticscholar +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source

